CD3 epsilon Recombinant Rabbit mAb (Alexa Fluor? 555 Conjugate) (S-241-49)

產(chǎn)品型號：S0B0212

更新時間：2025-07-01

廠商性質(zhì)：生產(chǎn)廠家

訪問量：36

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

CDx 抗體 | 新興靶點B7-H3/H4，助力ADC藥物研發(fā)

葉酸受體α在癌癥治療策略中的多面性

IHC腫瘤標志物 | 常見前列腺癌診斷

HA標簽重組兔單抗具有增強蛋白定位的能力

產(chǎn)品介紹

CD3 （cluster of differentiation 3） is a protein complex and T cell co-receptor that is involved in activating both the cytotoxic T cell （CD8+ naive T cells） and T helper cells （CD4+ naive T cells）. It is composed of four distinct chains. In mammals, the complex contains a CD3γ chain, a CD3δ chain, and two CD3ε chains. These chains associate with the T-cell receptor （TCR） and the CD3-zeta （ζ-chain） to generate an activation signal in T lymphocytes. The TCR, CD3-zeta, and the other CD3 molecules together constitute the TCR complex. The CD3–T cell receptor （TCR） complex plays a central role in the T-cell-mediated immunoresponse as it is involved in the recognition of antigens and subsequent signal transduction and activation of immunocompetent T lymphocytes. Because CD3 is required for T cell activation, drugs （often monoclonal antibodies） that target it are being investigated as immunosuppressant therapies （e.g., otelixizumab, teplizumab） for type 1 diabetes and other autoimmune diseases.

上一個：S0B0594Invivo anti-mouse PD-1 Recombinant mAb (D265A)